Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis

Discussion This phase III study demonstrated that Cinacalcet is effective and well tolerated in treating SHPT in Chinese chronic kidney disease patients on hemodialysis, and in a patient population with much higher baseline PTH levels.

Source: Hemodialysis International - January 1, 2016 Category: Hematology Authors: Changlin Mei, Nan Chen, Xiaoqiang Ding, Xueqing Yu, Li Wang, Jiaqi Qian, Mei Wang, Gengru Jiang, Xuemei Li, Fanfan Hou, Li Zuo, Niansong Wang, Hong Liu Tags: Original Article Source Type: research